January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Al-Ola Abdallah: Myeloma Drug Prices
Jan 25, 2025, 04:58

Al-Ola Abdallah: Myeloma Drug Prices

Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on X about a recent paper by Praneeth Reddy Keesari et al. published in Current Hematologic Malignancy Reports:

“Myeloma Drug Prices (from the expensive to the cheapest!)

  1. Cilta-Cel $507,000
  2. Ide-Cel $503,000
  3. Elrantamab $486,000/yr
  4. Selinexor $442,000/yr
  5. Talquetamab $372,000/yr
  6. Pomalidomide $300,000/yr
  7. Lenalidomide $240,000/yr
  8. Teclistimab $235,000/yr
  9. Carfilzomib $173,000/yr
  10. Daratumumab $165,000/yr
  11. Ixazomib $136,000/yr
  12. Cyclophosphamide $8,000/yr
  13. Bortezomib $2,000/yr
  14. Dexamethasone $570/yr.”

“Navigating the Economic Burden of Multiple Myeloma: Insights into Cost‑efectiveness of CAR‑T and Bispecifc Antibody Therapies”

Authors: Praneeth Reddy Keesari, Diana Samuels, Charan Thej Reddy Vegivinti, Yashwitha Sai Pulakurthi, Revathi Kudithi, Meekoo Dhar, Murali Janakiram.

Al-Ola Abdallah: Myeloma Drug Prices

More posts featuring Al-Ola Abdallah.